Offices:
Copenhagen
Average round investment:
39.42M USD
Lundbeckfond Ventures is an evergreen life science venture fund investing in life science companies primarily in Europe, up to €50 million annualy.
Lundbeckfonden Ventures aims to support the group's activities and operating independently from the Lundbeckfonden’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.
We tracked 11 Nordic investments.
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Lundbeckfond Ventures investments breakdown analysis:
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Lundbeckfond Ventures mostly invests with:
You need an account to access this feature.
Login or create one from
here.
(it takes 20 seconds)
Investors with similar profile to Lundbeckfond Ventures:
| Investor | Criteria |
|---|
 Sunstone Life Science Ventures75% | - Range for average deal size: 20M - 50M USD
- Similar verticals: Biotech, Health services, Pharma
- Similar business models: B2B
- Common investees countries: Denmark
- Average number of deals per year: 1.5
- Active last 12 months: Yes
|
| Novo A/S 72% | - Range for average deal size: 20M - 50M USD
- Similar verticals: Biotech, Health services, Pharma
- Similar business models: B2B
- Common investees countries: Denmark
- Average number of deals per year: 2.1
|
| Sofinnova Partners 72% | - Range for average deal size: 20M - 50M USD
- Similar verticals: Biotech, Health services, Pharma
- Similar business models: B2B
- Common investees countries: Denmark
- Average number of deals per year: 1.6
|
| Novo Seeds 70% | - Range for average deal size: 20M - 50M USD
- Similar verticals: Biotech, Health services, Pharma
- Similar business models: B2B
- Common investees countries: Denmark
- Average number of deals per year: 3.2
|
 Idinvest Partners69% | - Range for average deal size: 20M - 50M USD
- Similar verticals: Biotech, Health services, Pharma
- Similar business models: B2B
- Common investees countries: Denmark
- Average number of deals per year: 3.8
|
| Kurma Life Science Partners 68% | - Range for average deal size: 20M - 50M USD
- Similar verticals: Biotech, Health services, Pharma
- Similar business models: B2B
- Average number of deals per year: 1.5
|
 HealthCap63% | - Range for average deal size: 20M - 50M USD
- Similar verticals: Biotech, Health services
- Similar business models: B2B
- Average number of deals per year: 1.5
- Active last 12 months: Yes
|
| Seventure Partners 62% | - Range for average deal size: 20M - 50M USD
- Similar verticals: Biotech, Health services
- Similar business models: B2B
- Common investees countries: Denmark
- Average number of deals per year: 1.7
|
 Novartis Venture Fund56% | - Range for average deal size: 20M - 50M USD
- Similar verticals: Health services
- Similar business models: B2B
- Average number of deals per year: 1.5
- Active last 12 months: Yes
|
 LSP (Life Sciences Partners)54% | - Range for average deal size: 20M - 50M USD
- Similar verticals: Health services
- Similar business models: B2B
- Average number of deals per year: 1.4
- Active last 12 months: Yes
|
